Mark Eccleston
Hoofd Techniek/Wetenschap/O&O bij VOLITIONRX LIMITED
Profiel
Mark Eccleston was the founder of Vivamer Ltd.
(founded in 2002) and held the title of Chief Scientific Officer from 2002 to 2006.
He is currently the Director of Business Development at Volition, Inc., the Managing Director at Oncolytika Ltd.
(since 2010), and the Chief Technology Officer at VolitionRX Ltd.
Dr. Eccleston's former job was as the Director of ADD Signs Ltd.
(2010-2017).
He obtained an MBA from the University of Dundee in 2008 and a doctorate from the University of Aston in 1998.
Actieve functies van Mark Eccleston
| Bedrijven | Functie | Begin |
|---|---|---|
| VOLITIONRX LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-02-2021 |
Volition, Inc.
 Volition, Inc. Packaged SoftwareTechnology Services Volition, Inc. operates as a video game developer firm. The company was founded on March 14, 1997 and is headquartered in Champaign, IL. | Corporate Officer/Principal | - |
Oncolytika Ltd.
 Oncolytika Ltd. Miscellaneous Commercial ServicesCommercial Services Oncolytika Ltd. is a British technical consultancy company that provides research and development services in biotechnology. The private company is based in Cambridgeshire, UK. Mark Eccleston has been the CEO of the company since 2010. | Algemeen Directeur | 01-06-2010 |
Eerdere bekende functies van Mark Eccleston
| Bedrijven | Functie | Einde |
|---|---|---|
ADD Signs Ltd.
 ADD Signs Ltd. Miscellaneous ManufacturingProducer Manufacturing ADD Signs Ltd. provides a professional service designing and manufacturing architectural and retail sign systems. Its services include signs, graphics, development and property, and vehicles. The company is headquartered in Liverpool, the United Kingdom. | Directeur/Bestuurslid | 03-02-2017 |
Vivamer Ltd.
 Vivamer Ltd. BiotechnologyHealth Technology Vivamer Ltd. manufactures drugs based on biopolymer chemistry. The firm’s polymer chemistry platform provides a unique and novel drug delivery system. It protects traditional molecule and biotech drugs from degradation in the body. The company was founded by Nigel Slater and Mark Eccleston on December 3, 2002 and is headquartered in Cambridge, the United Kingdom. | Algemeen Directeur | - |
Opleiding van Mark Eccleston
| University Of Dundee | Masters Business Admin |
| University of Aston | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VOLITIONRX LIMITED | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Volition, Inc.
Volition, Inc. Packaged SoftwareTechnology Services Volition, Inc. operates as a video game developer firm. The company was founded on March 14, 1997 and is headquartered in Champaign, IL. | Technology Services |
Vivamer Ltd.
Vivamer Ltd. BiotechnologyHealth Technology Vivamer Ltd. manufactures drugs based on biopolymer chemistry. The firm’s polymer chemistry platform provides a unique and novel drug delivery system. It protects traditional molecule and biotech drugs from degradation in the body. The company was founded by Nigel Slater and Mark Eccleston on December 3, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
ADD Signs Ltd.
ADD Signs Ltd. Miscellaneous ManufacturingProducer Manufacturing ADD Signs Ltd. provides a professional service designing and manufacturing architectural and retail sign systems. Its services include signs, graphics, development and property, and vehicles. The company is headquartered in Liverpool, the United Kingdom. | Producer Manufacturing |
Oncolytika Ltd.
Oncolytika Ltd. Miscellaneous Commercial ServicesCommercial Services Oncolytika Ltd. is a British technical consultancy company that provides research and development services in biotechnology. The private company is based in Cambridgeshire, UK. Mark Eccleston has been the CEO of the company since 2010. | Commercial Services |
